Our work
Reflecting on a groundbreaking year
This week, we published our Annual Report for the 2022/23 financial year, and I couldn’t be more excited to reflect on such a momentous year for progress, both in dementia research and at Alzheimer’s Research UK.
The outlook for dementia is changing, and so are we
Our Chief Executive Hilary Evans reflects on the changing outlook for dementia research, and why it’s time to strive for a cure.
How your support is helping us keep dementia research going
Your support is continuing to fund research like this that will make our mission to bring about a life-changing dementia treatment for people possible.
COVID-19: the impact for dementia research and our work
As we all adapt to a temporary, extraordinary new way of living, we wanted to update you on how we’re adapting at Alzheimer’s Research UK, and the potential impact of COVID-19 on dementia research.
Alzheimer’s Research UK supports tracking COVID-19 symptoms with new app
The COVID-19 Symptom Tracker app, developed by King’s College London, is joining forces with the UK’s largest health-based charities. The aim is to reach people most at risk of COVID-19, including those with pre-existing health conditions such as dementia, diabetes, heart disease and those over the age of 70.
COVID-19 – The dementia research field adapts
People with dementia are likely to be particularly vulnerable to this virus so it is especially important that they and those around them take what steps they can to avoid transmission.
COVID-19: A message for our supporters
We’re acutely aware of the impact the outbreak will be having on people with dementia and their families, exacerbating an already unprecedented situation. Our hearts go out to everyone in such circumstances.
How can wearables revolutionise the detection of dementia?
The Early Detection of Neurodegenerative diseases (EDoN) initiative is spearheaded by Alzheimer’s Research UK and brings together 14 leading research and support organisations, working to develop innovative ways to pick up these diseases in the brain years before the symptoms of dementia start.
It’s time to change the conversation
To accelerate progress towards life-changing treatments, we must also change the conversation about dementia.
